Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is caused by novel coronavirus disease 2019 virus (COVID‐19). Cardiac manifestations and injury  were identified in up to 20–28% of patients.<unk><unk><unk><unk>  (SCAD) is one of the cardiac complication of covid-19 and can be  either atherosclerotic or non-atherosclerotic resulting  from  attaching covid-19 to ACE receptos of vessles wall and producing intense inflammation and endothelial dysfunction, sympathetic over-reactivity that are the precursors of intimal<unk> . SCAD can be manifested as STEMI or NSTEMI  in patients with covid-19 in which high clinical suspicion is warranted before administration of fibrinolysis in such patients.  Among nine reported cases of covid-19 associated SCAD there were not found any previous conventional risk factors of SCAD such as fibromuscular disease, steraneous  physical exercise, sex hormone, or peripartum period, except one case reported after intense cough in hospitalized covid-19 patients. In reported covid-19 patients associated with SCAD, it was more common in men and all nine cases were survived with consevative therapy or percutaneous<unk>  intervention based upon the anatomical site of<unk> .
COVID-19-associated spontaneous coronary artery dissection
COVID-19-associated arrhythmia and conduction system disease
COVID-19-associated myocardial injury
COVID-19-associated stress cardiomyopathy
COVID-19-associated cardiogenic shock
COVID-19-associated myocardial infarction
COVID-19-associated pulmonary embolism
COVID-19-associated heart failure